# Xenon Pharmaceuticals Inc.: filings

XENE · Nasdaq · CIK 1582313 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xene.md) · [Financials](/companies/xene/financials.md) · [Filings](/companies/xene/filings.md) · [Insiders](/companies/xene/insiders.md)

## Reports and events: 210 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 332, 8-K 142, SC 13G/A 47, 10-Q 36, 144 35, 3 33, 424B5 22, SC 13G 16, S-8 15, CT ORDER 13, 10-K 12, DEF 14A 12, CORRESP 10, S-8 POS 10, SCHEDULE 13G/A 9, UPLOAD 8, ARS 5, 4/A 4, EFFECT 4, 10-Q/A 3, DRS/A 3, FWP 3, S-3 3, 8-K/A 2, DEFA14A 2, S-1/A 2, S-3ASR 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, DRSLTR 1, S-1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 20:31 ET | [10-Q](/filings/0001193125-26-338244.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338244 |
| 2026-08-06 | 20:11 ET | [8-K](/filings/0001193125-26-338019.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-338019 |
| 2026-06-03 | 20:02 ET | [8-K](/filings/0001193125-26-255396.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-255396 |
| 2026-05-07 | 20:35 ET | [10-Q](/filings/0001193125-26-212153.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212153 |
| 2026-05-07 | 20:02 ET | [8-K](/filings/0001193125-26-211843.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-211843 |
| 2026-04-22 | 20:02 ET | [DEF 14A](/filings/0001193125-26-170320.md) | Proxy statement, period 2026-04-22 | 0001193125-26-170320 |
| 2026-04-13 | 20:01 ET | [8-K](/filings/0001193125-26-152834.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-152834 |
| 2026-03-13 | 20:10 ET | [8-K](/filings/0001193125-26-106144.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-106144 |
| 2026-03-12 | 20:17 ET | [8-K](/filings/0001193125-26-104199.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-104199 |
| 2026-03-09 | 11:36 ET | [8-K](/filings/0001193125-26-097577.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097577 |
| 2026-02-27 | 21:03 ET | [8-K](/filings/0001193125-26-082520.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-082520 |
| 2026-02-26 | 21:12 ET | [10-K](/filings/0001193125-26-076650.md) | Annual report, period 2025-12-31 | 0001193125-26-076650 |
| 2026-02-26 | 21:03 ET | [8-K](/filings/0001193125-26-076530.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-076530 |
| 2025-12-01 | 21:05 ET | [8-K](/filings/0001193125-25-303862.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-303862 |
| 2025-11-03 | 21:31 ET | [10-Q](/filings/0001193125-25-262646.md) | Quarterly report, period 2025-09-30 | 0001193125-25-262646 |
| 2025-11-03 | 21:04 ET | [8-K](/filings/0001193125-25-262519.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-262519 |
| 2025-10-17 | 20:37 ET | [8-K/A](/filings/0001193125-25-242583.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242583 |
| 2025-10-16 | 21:16 ET | [8-K](/filings/0001193125-25-241546.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-241546 |
| 2025-08-11 | 20:32 ET | [10-Q](/filings/0000950170-25-106599.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106599 |
| 2025-08-11 | 20:04 ET | [8-K](/filings/0000950170-25-106529.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106529 |
| 2025-07-03 | 21:22 ET | [8-K](/filings/0000950170-25-093996.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-093996 |
| 2025-06-05 | 21:07 ET | [8-K](/filings/0000950170-25-082494.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-082494 |
| 2025-05-12 | 20:40 ET | [10-Q](/filings/0000950170-25-069342.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069342 |
| 2025-05-12 | 20:07 ET | [8-K](/filings/0000950170-25-069183.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-069183 |
| 2025-04-24 | 20:22 ET | [DEF 14A](/filings/0000950170-25-058086.md) | Proxy statement, period 2025-04-24 | 0000950170-25-058086 |
| 2025-03-17 | 20:39 ET | [8-K](/filings/0000950170-25-040381.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-040381 |
| 2025-03-05 | 21:25 ET | [8-K](/filings/0000950170-25-033653.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-033653 |
| 2025-02-27 | 21:39 ET | [10-K](/filings/0000950170-25-029149.md) | Annual report, period 2024-12-31 | 0000950170-25-029149 |
| 2025-02-27 | 21:04 ET | [8-K](/filings/0000950170-25-029010.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-029010 |
| 2025-01-17 | 14:01 ET | [8-K](/filings/0000950170-25-006495.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-006495 |
| 2024-11-12 | 21:36 ET | [10-Q](/filings/0000950170-24-125547.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125547 |
| 2024-11-12 | 21:09 ET | [8-K](/filings/0000950170-24-125374.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-125374 |
| 2024-08-08 | 20:36 ET | [10-Q](/filings/0000950170-24-094109.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094109 |
| 2024-08-08 | 20:08 ET | [8-K](/filings/0000950170-24-093933.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-093933 |
| 2024-06-05 | 20:12 ET | [8-K](/filings/0000950170-24-069318.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-069318 |
| 2024-05-09 | 20:35 ET | [10-Q](/filings/0000950170-24-057139.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057139 |
| 2024-05-09 | 20:09 ET | [8-K](/filings/0000950170-24-056940.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-056940 |
| 2024-04-26 | 20:26 ET | [DEF 14A](/filings/0000950170-24-049198.md) | Proxy statement, period 2024-04-26 | 0000950170-24-049198 |
| 2024-04-19 | 20:21 ET | [8-K](/filings/0000950170-24-046023.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-046023 |
| 2024-03-08 | 22:27 ET | [8-K](/filings/0000950170-24-028784.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-028784 |
| 2024-02-29 | 21:36 ET | [10-K](/filings/0000950170-24-023177.md) | Annual report, period 2023-12-31 | 0000950170-24-023177 |
| 2024-02-29 | 21:10 ET | [8-K](/filings/0000950170-24-023080.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-023080 |
| 2023-11-30 | 21:15 ET | [8-K](/filings/0000950170-23-067040.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-067040 |
| 2023-11-27 | 12:03 ET | [8-K](/filings/0000950170-23-066032.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-066032 |
| 2023-11-09 | 21:06 ET | [8-K](/filings/0000950170-23-062022.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-062022 |
| 2023-11-08 | 21:36 ET | [10-Q](/filings/0000950170-23-061200.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061200 |
| 2023-11-08 | 21:11 ET | [8-K](/filings/0000950170-23-061119.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-061119 |
| 2023-08-09 | 20:38 ET | [10-Q](/filings/0000950170-23-040681.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040681 |
| 2023-08-09 | 20:16 ET | [8-K](/filings/0000950170-23-040608.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-040608 |
| 2023-08-08 | 20:07 ET | [8-K](/filings/0000950170-23-039782.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-039782 |

Page 1 of 5. [Older](/companies/xene/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.